Position Papers

Do you have a Cloud Hangover?

Many organizations, eyeing their cloud adoption initiatives in the rearview mirror, are beginning to suffer some buyer’s remorse. Either the promise of the public cloud has failed to materialize, or perhaps sights were set on the wrong goals to begin with. A misapplication of the

AI is reforming the Radiational Oncology Market in Real Time

The rate of change in the field of oncology has continued to accelerate, with an information doubling expected to occur every two months – or expanding at the rate of 64x per year. The oncology field has long since crossed the line that individuals can

Golden Age of Molecular Diagnostics

Recently, the New York Times had an article on Page 1, above the fold, titled, “Suddenly, It Looks Like We’re in a Golden Age for Medicine”. As the piece describes, the explosion of the utility of new biotech technologies, from CRISPR to mRNA, is leading

Competing in the Enormously Competitive Surgical Robot Space

Intuitive Surgical shipped their first surgical Robotic Assisted Surgery (RAS) in 1998. In the twenty-five years since, the technology has become ingrained in most surgical procedures. Incredibly, the market itself is projected to grow 7-fold over the next 7 years. This growth has created a

Evolving Digital Health Impacts EP

The expanding impact of Digital Health and Digital Therapeutics is being felt by the EP sector.  Remote monitoring of implantable cardiac devices (ICDs), cardiac resynchronization therapy devices (CRT-Ds), and pacemakers have been shown to improve patient outcomes. More recent work applying convolution neural network (CNN)

Rapid Changes to the Healthcare Information Ecosystem

The pressure to extend product capabilities within the healthcare information systems industry has gone through cycles over the past few decades, but it has never been higher than it is right now. If you were to look at the HIMSS education track from ten years

Remote Cardiac Monitoring: New Challenges with the New Normal

Pressure continues to mount to reduce the use of in-hospital resources in order to improve the cost performance of healthcare. Developing more cost-effective methods of addressing cardiac-related illness, still the number one cause of death in the US, is a high priority. Remote monitoring and

Leveraging AI in Radiation Oncology: What You Need to Know

The radiation oncology (RO) market continues to change rapidly. Efforts with the goals of improving the effectiveness of treatment, while reducing costs, and preventable treatment errors is driving the new capabilities into both delivery and treatment planning systems. In a change from recent years, a

FDA Steps Up its Cyber Security Vigilance

Full Spectrum is often engaged to assess software cybersecurity for our clients.  So, when the FDA issued its new draft guidance to the MedDevice industry (Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions | FDA – April 8. 2022) we expected

What Has Covid Taught us about Medical Device Development?

Like most sectors of the US economy, the Covid pandemic has laid bare every existing product development challenge that the Medical Device industry has had for years. In March of 2020, when Covid cases started spiking and emergency orders closed offices and manufacturing plants across

AI is reforming the Radiational Oncology Market in Real Time

The rate of change in the field of oncology has continued to accelerate, with an information doubling expected to occur every two months – or expanding at the rate of 64x per year. The oncology field has long since crossed the line that individuals can

Golden Age of Molecular Diagnostics

Recently, the New York Times had an article on Page 1, above the fold, titled, “Suddenly, It Looks Like We’re in a Golden Age for Medicine”. As the piece describes, the explosion of the utility of new biotech technologies, from CRISPR to mRNA, is leading

Competing in the Enormously Competitive Surgical Robot Space

Intuitive Surgical shipped their first surgical Robotic Assisted Surgery (RAS) in 1998. In the twenty-five years since, the technology has become ingrained in most surgical procedures. Incredibly, the market itself is projected to grow 7-fold over the next 7 years. This growth has created a

Evolving Digital Health Impacts EP

The expanding impact of Digital Health and Digital Therapeutics is being felt by the EP sector.  Remote monitoring of implantable cardiac devices (ICDs), cardiac resynchronization therapy devices (CRT-Ds), and pacemakers have been shown to improve patient outcomes. More recent work applying convolution neural network (CNN)

Rapid Changes to the Healthcare Information Ecosystem

The pressure to extend product capabilities within the healthcare information systems industry has gone through cycles over the past few decades, but it has never been higher than it is right now. If you were to look at the HIMSS education track from ten years

Remote Cardiac Monitoring: New Challenges with the New Normal

Pressure continues to mount to reduce the use of in-hospital resources in order to improve the cost performance of healthcare. Developing more cost-effective methods of addressing cardiac-related illness, still the number one cause of death in the US, is a high priority. Remote monitoring and

Leveraging AI in Radiation Oncology: What You Need to Know

The radiation oncology (RO) market continues to change rapidly. Efforts with the goals of improving the effectiveness of treatment, while reducing costs, and preventable treatment errors is driving the new capabilities into both delivery and treatment planning systems. In a change from recent years, a

FDA Steps Up its Cyber Security Vigilance

Full Spectrum is often engaged to assess software cybersecurity for our clients.  So, when the FDA issued its new draft guidance to the MedDevice industry (Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions | FDA – April 8. 2022) we expected

What Has Covid Taught us about Medical Device Development?

Like most sectors of the US economy, the Covid pandemic has laid bare every existing product development challenge that the Medical Device industry has had for years. In March of 2020, when Covid cases started spiking and emergency orders closed offices and manufacturing plants across